Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07101250

Preoperative Acetazolamide

The goal of this randomized study looks at whether giving patients a medicine called acetazolamide (also called Diamox) before they have laparoscopic hysterectomy may decrease postoperative pain. Researchers will compare acetazolamide to a placebo or inactive drug, to see if acetazolamide helps the pain that may occur after surgery from the gas used in the abdomen during the laparoscopic procedure. Patients will be asked to rate their pain before surgery and after surgery through 24 hours.

Recruiting

Interested in participating?

Request Info

Key information

Age range

21 year–65 year

Sex eligibility

Female

Study type

Interventional

Phase

Phase 4

Primary location

Prisma Health

Greenville, South Carolina, 29605, United States

Location status: Recruiting

Location contact

Patti Parker, BSN

CONTACT

[email protected]

864-455-1510

About this study

Pain control following surgery is integral to surgical success, allowing faster recovery and return to function and increasing patient satisfaction. Minimally invasive surgery, such as laparoscopy, is becoming increasingly common as it involves smaller incisions and theoretically less discomfort. However, in order to perform laparoscopy, one must insufflate the abdomen with gas in order to create space in which to operate. The most commonly used gas today is carbon dioxide, as it is highly soluble and reduces the risk of air embolism compared to room air if absorbed. A consequence of using carbon dioxide is that it is converted to carbonic acid that can be irritating to the peritoneum and specifically the diaphragm, causing referred pain to the right subscapular (shoulder) region. Multiple strategies have been undertaken to help reduce this discomfort, one of which is using acetazolamide (a carbonic anhydrase inhibitor) to help reduce peritoneal acidification. Multiple studies have demonstrated an improvement in shoulder pain following preoperative administration in laparoscopic cholecystectomy, but studies evaluating use in pelvic surgery have had mixed results. The goal of this study is to add to this understanding and determine if acetazolamide is a useful adjunct to current pain control methods in laparoscopic gynecologic surgery.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Women
  • Ages 21-65
  • undergoing total laparoscopic hysterectomy (TLH) for benign indications with or without bilateral salpingoophorectomy
  • undergoing total laparoscopic hysterectomy (TLH) for benign indications with or without cystoscopy

Exclusion criteria

  • Allergy to acetazolamide or sulfonamides
  • Known electrolyte disturbances
  • Pregnancy
  • Kidney failure or creatinine >1.5
  • Diuretic or lithium use
  • Chronic obstructive pulmonary disease (COPD) or other lung disease
  • Central nervous system disorders
  • Liver disease
  • Glaucoma
  • Preoperative or chronic opioid use
  • Diagnosis of fibromyalgia
  • Preoperative shoulder pain
  • Conversion to laparotomy
  • Intraoperative bladder or bowel injury
  • Inability to understand or utilize visual analog scale
  • Undergoing concurrent reconstructive procedures

Treatment and study plan

Acetazolamide 500 MG Extended Release Oral Capsule

Drug

Active Drug

Other names: Diamox

Placebo

Drug

Inactive Drug

Primary outcomes

  1. Abdominal/pelvic pain and right subscapular pain rated on a VAS at five perioperative points

    Time frame: From before procedure to 24 hours post procedure

    Baseline score at preoperative time point and 4 time points post operative

  2. Total analgesic use postoperatively

    Time frame: from end of procedure to 24 hours post procedure

    analgesic use in the post operative period will be calculated in morphine equivalents

Study contacts

Contact information is provided by the study sponsor or research team.

Patti Parker, BSN

CONTACT

[email protected]

864-455-1510

Paul Miller, MD

CONTACT

[email protected]

864-455-1600

Sponsors and collaborators

Lead sponsor

Prisma Health-Upstate

Other

Registry information

Official study title

Preoperative Acetazolamide for Improved Pain Control Following Laparoscopic Hysterectomy

Important dates

Study start
2025
Primary completion
2026
Study completion
2026
First posted
Aug 3, 2025
Registry last updated
Feb 20, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.